Skip to main content
. 2023 Apr 23;10(18):2301339. doi: 10.1002/advs.202301339

Figure 9.

Figure 9

Microneedles and 3D scaffolds promoting DCs in tumor immunotherapy. a) Schematic illustration of microneedle‐based transdermal vaccination for activating DCs. Reproduced with permission.[ 208 ] Copyright 2017, American Association for the Advancement of Science. b) Formation and mechanism of the DC‐based vaccine nodule engineered in the peptide nanofibrous hydrogel. Reproduced with permission.[ 45 ] Copyright 2018, American Chemical Society. c) Schematic of the implantable blood clot vaccine. Reproduced with permission.[ 214 ] Copyright 2020, American Association for the Advancement of Science.